Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused…
9,030$
-2,54%
Echtzeit-Aktienkurs SENSEI BIOTHER. DL -,0001
Bid:
Ask:
Nachrichten zur SENSEI BIOTHER. DL -,0001 Aktie
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused…